TIPARP and cancer: Differently from the immunomodulatory effect observed in the other cancer cell lines, in this case, the antitumor activity is mainly related to the ability of the compound to freeze PARP7 into the nucleus, generating cytostatic and cytotoxic effects and without blocking a specific phase of cell cycle [101].